SIADH-related hyponatremia in hospital day care units: clinical experience and management with tolvaptan

• DOI: 10.1007/s00520-015-2948-6
• Publication Date: 2015-10-02T07:04:44Z
• Authors: Ramón De las Peñas; Santiago Ponce; Fernando Henao; Carlos Camps Herrero; Enric Carcereny; Yolanda Escobar Á...; César A. Rodríguez; Juan Antonio Viri...; Rafael López López
• Keywords: Tolvaptan; Electrolyte Disorder

Hyponatremia (Na ˂135 mmol/l) is the most frequent electrolyte disorder in clinical practice, and syndrome of inappropriate antidiuretic hormone secretion (SIADH) commonest cause hyponatremia cancer patients. Correcting these patients can reduce morbidity mortality, increase response to anti-cancer agents, help hospital length stay costs. Tolvaptan an oral medication used treat SIADH-related that needs be initiated at so have their serum sodium monitored. If tolvaptan could day care units (DCUs), performing same tests, hospitalization avoided, quality life improved, costs reduced. This first publication where a panel oncologists are sharing experience making some recommendations with use DCU after collecting examining 35 cases type The conclusion from this retrospective observational analysis safe effective therapeutic management hyponatremia.